GENX Stock Overview
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Genix Pharmaceuticals Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.04 |
| 52 Week High | CA$0.09 |
| 52 Week Low | CA$0.015 |
| Beta | -0.43 |
| 11 Month Change | -20.00% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 33 Year Change | -72.41% |
| 5 Year Change | -42.86% |
| Change since IPO | -84.00% |
Recent News & Updates
Shareholder Returns
| GENX | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | -20.0% | -3.2% | 0.7% |
| 1Y | 0% | 4.2% | 21.7% |
Return vs Industry: GENX underperformed the Canadian Personal Products industry which returned 4.9% over the past year.
Return vs Market: GENX underperformed the Canadian Market which returned 21.4% over the past year.
Price Volatility
| GENX volatility | |
|---|---|
| GENX Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 9.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: GENX's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine GENX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Sina Pirooz | www.genixpharm.com |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to support kidney health; and Sucanon, a herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops.
Genix Pharmaceuticals Corporation Fundamentals Summary
| GENX fundamental statistics | |
|---|---|
| Market cap | CA$2.96m |
| Earnings (TTM) | -CA$4.00m |
| Revenue (TTM) | CA$3.98k |
594.8x
P/S Ratio-0.6x
P/E RatioIs GENX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GENX income statement (TTM) | |
|---|---|
| Revenue | CA$3.98k |
| Cost of Revenue | CA$1.68k |
| Gross Profit | CA$2.30k |
| Other Expenses | CA$4.00m |
| Earnings | -CA$4.00m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.067 |
| Gross Margin | 57.77% |
| Net Profit Margin | -100,366.41% |
| Debt/Equity Ratio | -54.2% |
How did GENX perform over the long term?
See historical performance and comparison